-
Business

Novartis Wins Swiss Approval for First-Ever Malaria Drug for Newborns
Novartis has secured Swiss approval for Coartem Baby, the world’s first malaria drug formulated for newborns under 4.5kg. The treatment…
Read More » -
Business

Trump’s $3 Trillion ‘Beautiful Bill’ Reshapes Taxes, Cuts Safety Nets, and Bets Big on Enforcement
President Trump’s One Big Beautiful Bill Act rewrites the U.S. tax and welfare code, with deep implications for middle- and…
Read More » -
Business

SPY Drops to $620 as Tariff Jitters Hit Wall Street
The SPDR S&P 500 ETF Trust (SPY) slid to $620 as U.S. markets reeled from a new wave of tariffs.…
Read More » -
Business

Bondholders Challenge $7.4B Citgo Bid by Gold Reserve as Court Showdown Nears
Gold Reserve’s $7.4 billion bid for Citgo’s parent may face collapse as bondholders object and competing bidders offer more comprehensive…
Read More » -
Business

CoreWeave Acquires Core Scientific in $9 Billion Stock Deal to Lock Down AI Infrastructure
CoreWeave is buying Core Scientific for $9 billion in stock, bringing GPU capacity and power infrastructure under one roof. The…
Read More » -
Business

TikTok’s U.S. Only App Set for September Launch Ahead of Sale Deadline
ByteDance is building a standalone U.S. version of TikTok, expected to launch September 5, just ahead of a federal deadline…
Read More » -
Business

Costco Faces Expanding Recall Wave Across Multiple Product Lines
Costco is dealing with a surge of product recalls affecting air conditioners, power banks, fitness gear, tires, food, and more.…
Read More » -
Business

Why Wall Street Isn’t Flinching Ahead of Trump’s Tariff Deadline
As the U.S. tariff deadline approaches, global markets remain largely unfazed. Equity traders are looking past trade risks, while bond…
Read More » -
Business

U.S. Issues Trade Ultimatum as Tariff Deadline Nears
With a July 9 deadline looming, the U.S. has warned dozens of countries that tariffs paused since April are about…
Read More »









